Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Paul K Audhya, officer

Transaction date: April 16, 2026

Reporting date: April 20, 2026

Average share price: -15.235965712682379

Sold 3564.0 shares for 54300.98